Pulse corticosteroid therapy for alopecia areata: Long-term outcome after 10 years

Dermatology

Volumn 225, Issue 1, 2012, Pages 81-87

  Staumont Salle D ^a,b   Vonarx, M ^a   Lengrand, F ^a   Segard, M ^a   Delaporte, E ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Alopecia areata; Alopecia totalis; Alopecia universalis; Methylprednisolone bolus; Pulse corticosteroids

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; METHISOPRINOL; METHOTREXATE; METHYLPREDNISOLONE; MINOXIDIL; TACROLIMUS; ZINC;

ADOLESCENT; ADULT; ALOPECIA; ALOPECIA AREATA; ALOPECIA PLURIFOCALIS; ALOPECIA TOTALIS; ALTERNATIVE MEDICINE; ARTICLE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CRYOTHERAPY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERGLYCEMIA; LONG TERM CARE; MALE; NAUSEA AND VOMITING; PHOTOCHEMOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALOPECIA; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PULSE THERAPY, DRUG; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867746068     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000341523     Document Type: Article

References (31)

1. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J: Interventions for alopecia areata. Cochrane Database Syst Rev 2008; 2:CD004413.
2. Dillaha CJ, Rothman S: Therapeutic experiments in alopecia areata with orally administered cortisone. J Am Med Assoc 1952; 150: 546-550.
3. Winter RJ, Kern F, Blizzard RM: Prednisone therapy for alopecia areata. A follow-up report. Arch Dermatol 1976; 112: 1549-1552.
4. Burton JL, Shuster S: Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol 1975; 55: 493-496.
5. Tosti A, Bellavista S, Iorizzo M: Alopecia areata: A long-term follow-up study of 191 patients. J Am Acad Dermatol 2006; 55: 438- 441. (Pubitemid 44189598)
6. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
7. Luggen P, Hunziker T: High-dose intravenous corticosteroid pulse therapy in alopecia areata: Own experience compared with the literature. J Dtsch Dermatol Ges 2008; 6: 375- 378. (Pubitemid 351712825)
8. Perriard-Wolfensberger J, Pasche-Koo F, Mainetti C, Labarthe MP, Salomon D, Saurat JH: Pulse of methylprednisolone in alopecia areata. Dermatology 1993; 187: 282-285. (Pubitemid 23333942)
9. Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurat JH: Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 1998; 39: 597- 602. (Pubitemid 28465883)
10. Assouly P, Reygagne P, Jouanique C, Matard B, Marechal E, Reynert P, et al: Intravenous pulse methylprednisolone therapy for severe alopecia areata: An open study of 66 patients. Ann Dermatol Venereol 2003; 130: 326-330. (Pubitemid 36542233)
11. Kiesch N, Stene JJ, Goens J, Vanhooteghem O, Song M: Pulse steroid therapy for children's severe alopecia areata? Dermatology 1997; 194: 395-397. (Pubitemid 27290578)
12. Seiter S, Ugurel S, Tilgen W, Reinhold U: High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 2001; 202: 230-234. (Pubitemid 32506971)
13. Tsai YM, Chen W, Hsu ML, Lin TK: Highdose steroid pulse therapy for the treatment of severe alopecia areata. J Formos Med Assoc 2002; 101: 223-226. (Pubitemid 34578489)
14. Nakajima T, Inui S, Itami S: Pulse corticosteroid therapy for alopecia areata: Study of 139 patients. Dermatology 2007; 215: 320-324. (Pubitemid 47519261)
15. Tosti A, Guidetti MS, Bardazzi F, Misciali C: Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol 1996; 35: 199-201.
16. van der Steen PH, Boezeman JB, Happle R: Topical immunotherapy for alopecia areata: Re-evaluation of 139 cases after an additional follow-up period of 19 months. Dermatology 1992; 184: 198-201.
17. Hubiche T, Léauté-Labrèze C, Taïeb A, Boralevi F: Poor long-term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol 2008; 158: 1136-1137. (Pubitemid 351521428)
18. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG: Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149: 692-699. (Pubitemid 37419985)
19. Garg S, Messenger AG: Alopecia areata: Evidence-based treatments. Semin Cutan Med Surg 2009; 28: 15-18.
20. Shapiro J, Lui H, Tron V, Ho V: Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: A clinical and immunopathologic evaluation. J Am Acad Dermatol 1997; 36: 114-117. (Pubitemid 27043889)
21. Kim BJ, Min SU, Park KY, Choi JW, Park SW, Youn SW, et al: Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat 2008; 19: 216-220.
22. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J: Alopecia areata update. Part II. Treatment. J Am Acad Dermatol 2010; 62: 191-202.
23. Joly P: The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis. J Am Acad Dermatol 2006; 55: 632-636. (Pubitemid 44436626)
24. Chartaux E, Joly P: Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis. Ann Dermatol Venereol 2010; 137: 507-513.
25. Goh C, Finkel M, Christos PJ, Sinha AA: Profile of 513 patients with alopecia areata: Associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006; 20: 1055-1060. (Pubitemid 44425959)
26. Ghanizadeh A: Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol 2008; 47: 1118-1120.
27. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, et al: Psychiatric comorbidities in patients with alopecia areata in Taiwan: A case-control study. Br J Dermatol 2012; 166: 525-531.
28. Willemsen R, Vanderlinden J, Deconinck A, Roseeuw D: Hypnotherapeutic management of alopecia areata. J Am Acad Dermatol 2006; 55: 233-237. (Pubitemid 44037998)
29. Güleç AT, Tanriverdi N, Dürü C, Saray Y, Akçali C: The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43: 352-356. (Pubitemid 38714596)
30. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C, Richard MA, Loundou A, Auquier P, et al: Quality of life in alopecia areata: A study of 60 cases. J Invest Dermatol 2010; 130: 2830-2833.
31. Cartwright T, Endean N, Porter A: Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol 2009; 160: 1034-1039.